<PAGE> 1
OMB APPROVAL
OMB Number: 3235-0145
Expires:December 31, 1997
Estimated average burden
hours per response..14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ______________)*
Millennium Pharmaceuticals, Inc.
------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock
------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
59990210
------------------------------------------------------------------------------
(CUSIP NUMBER)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing of this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SEC 1745 (2-95)
<PAGE> 2
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mayfield VII, a California Limited Partnership
94-3167809
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California
5 SOLE VOTING POWER
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 1,614,169
OWNED BY EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH
8 SHARED DISPOSITIVE POWER
1,614,169
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,614,169
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7%
12 TYPE OF REPORTING PERSON*
PN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 3
CUSIP No. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mayfield VII Management Partners, a California Limited Partnership
94-3167811
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California
5 SOLE VOTING POWER
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 1,614,169
OWNED BY EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH
8 SHARED DISPOSITIVE POWER
1,614, 169
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,614,169
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7%
12 TYPE OF REPORTING PERSON*
PN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 4
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mayfield Associates Fund II, a California Limited Partnership
94-3191510
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California
5 SOLE VOTING POWER
NUMBER OF
SHARES 6 SHARED VOTING POWER 101,250
BENEFICIALLY
OWNED BY EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH
8 SHARED DISPOSITIVE POWER
101,250
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
101,250
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.4%
12 TYPE OF REPORTING PERSON*
PN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 5
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mayfield Medical Partners 1992, a California Partnership
94-3170955
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California
5 SOLE VOTING POWER
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 534,581
OWNED BY EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH
8 SHARED DISPOSITIVE POWER
534,581
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
534,581
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.2%
12 TYPE OF REPORTING PERSON*
PN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 6
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Yogen K. Dalal
Social Security Number: ###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
5 SOLE VOTING POWER
11,138
NUMBER OF
SHARES 6 SHARED VOTING POWER 2,250,000
BENEFICIALLY
OWNED BY EACH 7 SOLE DISPOSITIVE POWER
REPORTING 11,138
PERSON WITH
8 SHARED DISPOSITIVE POWER
SEE NUMBER 6 ABOVE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,261,138
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.5%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 7
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
F. Gibson Myers, Jr.
Social Security Number: ###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
5 SOLE VOTING POWER
19,651
NUMBER OF
SHARES 6 SHARED VOTING POWER 2,250,000
BENEFICIALLY
OWNED BY EACH 7 SOLE DISPOSITIVE POWER
REPORTING 19,651
PERSON WITH
8 SHARED DISPOSITIVE POWER
SEE NUMBER 6 ABOVE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,269,651
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.5%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 8
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kevin A. Fong
Social Security Number: ###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
5 SOLE VOTING POWER
13,844
NUMBER OF
SHARES 6 SHARED VOTING POWER 2,250,000
BENEFICIALLY
OWNED BY EACH 7 SOLE DISPOSITIVE POWER
REPORTING 13,844
PERSON WITH
8 SHARED DISPOSITIVE POWER
SEE NUMBER 6 ABOVE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,263,844
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.5%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 9
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William D. Unger
Social Security Number: ###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
5 SOLE VOTING POWER
13,312
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 2,250,000
OWNED BY EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH 13,312
8 SHARED DISPOSITIVE POWER
SEE NUMBER 6 ABOVE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,263,312
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.5%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 10
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Wendell G. Van Auken, III
Social Security Number: ###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
5 SOLE VOTING POWER
13,094
NUMBER OF
SHARES 6 SHARED VOTING POWER 2,250,000
BENEFICIALLY
OWNED BY EACH 7 SOLE DISPOSITIVE POWER
REPORTING 13,094
PERSON WITH
8 SHARED DISPOSITIVE POWER
SEE NUMBER 6 ABOVE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,263,094
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.5%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 11
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Michael J. Levinthal
Social Security Number: ###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
5 SOLE VOTING POWER
16,219
NUMBER OF
SHARES 6 SHARED VOTING POWER 2,250,000
BENEFICIALLY
OWNED BY EACH 7 SOLE DISPOSITIVE POWER
REPORTING 16,219
PERSON WITH
8 SHARED DISPOSITIVE POWER
SEE NUMBER 6 ABOVE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,266,219
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.5%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 12
CUSIP NO. 59990210 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
A. Grant Heidrich, III
Social Security Number: ###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /x/
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
5 SOLE VOTING POWER
39,741
NUMBER OF
SHARES 6 SHARED VOTING POWER 2,250,000
BENEFICIALLY
OWNED BY EACH 7 SOLE DISPOSITIVE POWER
REPORTING 39,741
PERSON WITH
8 SHARED DISPOSITIVE POWER
SEE NUMBER 6 ABOVE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,289,741
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.6%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 13
ITEM 1.
(a) Name of Issuer:
Millennium Pharmaceuticals, Inc.
(b) Address of Issuer's Principal Executive Offices:
640 Memorial Drive
Cambridge, MA 02139
ITEM 2.
(a) Name of Person(s) Filing:
Mayfield VII, a California Limited Partnership
Mayfield VII Management Partners, a California Limited Partnership
Mayfield Associates Fund II, a California Limited Partnership
Mayfield Medical Partners 1992, a California Partnership
Yogen K. Dalal F. Gibson Myers, Jr.
Kevin A. Fong William D. Unger
Wendell G. Van Auken, III Michael J. Levinthal
A. Grant Heidrich, III
(For a list of the general partners of the limited partnerships
listed above, see EXHIBIT C.)
(b) Address of Principal Office:
The entities and individuals listed in Item 2(a) share the following
business address:
The Mayfield Fund
2800 Sand Hill Road
Menlo Park, CA 94025
(c) Citizenship:
The entities listed in Item 2(a) are California Limited
Partnerships.
The individuals listed in Item 2(a) are U.S. citizens.
(d) Title of Class of Securities:
Common Stock
(e) CUSIP Number: 59990210
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B), CHECK
WHETHER THE PERSON IS A:
(a)/ /Broker or Dealer registered under Section 15 of the Act
<PAGE> 14
(b)/ /Bank as defined in section 3(a)(6) of the Act
(c)/ /Insurance Company as defined in section 3(a)(19) of the Act
(d)/ /Investment Company registered under section 8 of the Investment
Company Act
(e)/ /Investment Adviser registered under section 203 of the Investment
Advisers Act of 1940
(f)/ /Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of 1974 or
Endowment Fund, see Section240.13d-1(b)(1)(ii)(F)
(g)/ /Parent Holding Company, in accordance with
Section240.13d-1(b)(ii)(G) (Note: See Item 7)
(h)/ /Group, in accordance with Section240.13d-1(b)(1)(ii)(H)
N/A
ITEM 4. OWNERSHIP
The information regarding ownership as set forth in Items 5-9 of Pages
2-11 hereto, is hereby incorporated by reference.
For a summary of total ownership by all Reporting Persons, see EXHIBIT A
hereto, which is hereby incorporated by reference.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
N/A
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
N/A
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
N/A
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
N/A
ITEM 10. CERTIFICATION
N/A
<PAGE> 15
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 13, 1997
----------------------------------------
Date
MAYFIELD VII,
A California Limited Partnership
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Authorized Signatory
MAYFIELD VII MANAGEMENT PARTNERS
A California Limited Partnership
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Authorized Signatory
MAYFIELD ASSOCIATES FUND II,
A California Limited Partnership
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Authorized Signatory
MAYFIELD MEDICAL PARTNERS 1992,
A California partnership
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Authorized Signatory
YOGEN K. DALAL
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Attorney In Fact
F. GIBSON MYERS, JR.
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Attorney In Fact
<PAGE> 16
KEVIN A. FONG
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Attorney In Fact
WILLIAM D. UNGER
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Attorney In Fact
WENDELL G. VAN AUKEN, III
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Attorney In Fact
MICHAEL J. LEVINTHAL
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Attorney In Fact
A. GRANT HEIDRICH, III
By: /s/ George A. Pavlov
--------------------------------------
George A. Pavlov, Attorney In Fact
Exhibits
- -------------------
A - Beneficial Ownership of Each Reporting Person
B - Statement Appointing Authorized Signer and Designated Filer
C - List of General Partners
<PAGE> 17
EXHIBIT A
BENEFICIAL OWNERSHIP OF EACH REPORTING PERSON
<TABLE>
<CAPTION>
NAME OF REPORTING PERSON NUMBER OF NUMBER OF PERCENT OF CLASS
------------------------ --------- --------- ----------------
SHARES HELD SHARES HELD BENEFICIALLY OWNED(1)
----------- ----------- ---------------------
OF RECORD BENEFICIALLY
--------- ------------
<S> <C> <C> <C>
Mayfield VII, 1,614,169 1,614,169 7%
a California Limited Partnership
Mayfield VII Management Partners, 0 1,614,169(2) 7%
a California Limited Partnership
Mayfield Associates Fund II, 101,250 101,250 0.4%
a California Limited Partnership
Mayfield Medical Partners 1992, a 534,581 534,581 2.2%
California Partnership
Yogen K. Dalal 11,138 2,261,138(3) 9.5%
F. Gibson Myers, Jr. 19,651 2,269,651(3) 9.5%
Kevin A. Fong 13,844 2,263,844(3) 9.5%
William D. Unger 13,312 2,263,312(3) 9.5%
Wendell G. Van Auken, III 13,094 2,263,094(3) 9.5%
Michael J. Levinthal 16,219 2,266,219(3) 9.5%
A. Grant Heidrich, III 39,741 2,289,741(3) 9.6%
---------- ----------- ---------------
Total 2,377,039 2,377,039 10.4%
</TABLE>
(1) The respective percentages set forth in this column were obtained by
dividing the number of shares in the third column by the aggregate number of
outstanding shares of Common Stock, which aggregate amount, according to the
cover page of the Issuer's Quarterly Report on Form 10-Q for the three month
period ended September 30, 1996, was 23,857,852
(2) Represents shares held of record by Mayfield VII, of which Mayfield VII
Management Partners is the sole General Partner.
(3) The individual Reporting Persons listed in column one are General Partners
of the General Partner of Mayfield VII and General Partners of Mayfield
Associates Fund II and Mayfield Medical Partners 1992. The shares indicated in
column two represent shares held of record by such individual Reporting Person,
with sole voting and investment power with respect thereto. The individual
Reporting Persons listed in column one may be deemed to have shared voting and
dispositive power over the 1,614,169 shares held of record by
<PAGE> 18
Mayfield VII, the 101,250 shares held of record by Mayfield Associates Fund II,
and the 534,581 shares held of record by Mayfield Medical Partners 1992.
<PAGE> 19
EXHIBIT B
STATEMENT APPOINTING DESIGNATED FILER AND AUTHORIZED SIGNATORY
Each of the undersigned entities and individuals (collectively, the
"Reporting Persons") hereby designates the entity listed in Column II of EXHIBIT
A hereto, or such other person or entity as is designated in writing by George
A. Pavlov (any such entity is referred to as the "Designated Filer") as the
beneficial owner to make filings of Schedules 13D and 13G (and any amendments
thereto) pursuant to Section 13(d) of the Securities Exchange Act of 1934 (the
"Exchange Act") and of Forms 3, 4 and 5 (and any amendments thereto) pursuant to
Section 16(a) of the Exchange Act (collectively, the "Reports") with respect to
the securities of the entities listed in Column I of EXHIBIT A hereto and with
respect to the securities of any other entity whose securities are now, or
hereafter become, publicly traded and whose securities are beneficially owned
(directly or indirectly) both by such Reporting Person and by such Designated
Entity (collectively, the "Companies").
Each Reporting Person hereby further authorizes and designates GEORGE
A. PAVLOV (the "Authorized Signatory") to execute and file on behalf of such
Reporting Person the Reports with respect to the securities of the Companies,
including all Schedules 13D and 13G and Forms 3, 4 and 5, and any amendments
thereto, that the Reporting Person may be required to file with the United
States Securities and Exchange Commission as a result of the Reporting Person's
ownership of, or transactions in securities of the Companies.
The authority of the Designated Filer and the Authorized Signatory
under this document with respect to each Reporting Person shall continue until
such Reporting Person is no longer required to file Schedules 13D or 13G or
Forms 3, 4 and 5 with respect to the Reporting Person's ownership of, or
transactions in, the securities of the Companies, unless earlier revoked in
writing. Each Reporting Person acknowledges that the Designated Filer and the
Authorized Signatory are not assuming any of the Reporting Person's
responsibilities to comply with Section 13(d) or Section 16 of the Exchange Act.
Date: February 10, 1997 MAYFIELD VI INVESTMENT
PARTNERS,
a California Limited Partnership
By: Mayfield VI Management Partners,
a California Limited Partnership,
Its General Partner
By: /s/ George A. Pavlov
--------------------
Authorized Signatory
1
<PAGE> 20
Date: February 10, 1997 MAYFIELD VI MANAGEMENT
PARTNERS,
a California Limited Partnership
By: /s/ George A. Pavlov
---------------------
Authorized Signatory
Date: February 10, 1997 MAYFIELD VII
a California Limited Partnership
By: Mayfield VII Management Partners,
a California Limited Partnership,
Its General Partner
By: /s/ George A. Pavlov
---------------------
Authorized Signatory
Date: February 10, 1997 MAYFIELD VII MANAGEMENT
PARTNERS,
a California Limited Partnership
By: /s/ George A. Pavlov
---------------------
Authorized Signatory
Date: February 10, 1997 MAYFIELD VIII,
a California Limited Partnership
By: Mayfield VIII Management, L.L.C.,
Its General Partner
By: /s/ George A. Pavlov
---------------------
Authorized Signatory
2
<PAGE> 21
Date: February 10, 1997 MAYFIELD VIII MANAGEMENT, L.L.C.,
a Delaware Limited Liability Company
By: /s/ George A. Pavlov
-------------------------------
Authorized Signatory
Date: February 10, 1997 MAYFIELD SOFTWARE TECHNOLOGY
PARTNERS,
a California Partnership
By: Mayfield VI Investment Partners,
a California Limited Partnership,
Its General Partner
By: Mayfield VI Management Partners,
a California Limited Partnership,
Its General Partner
By: /s/ George A. Pavlov
--------------------------------
Authorized Signatory
Date: February 10, 1997 MAYFIELD MEDICAL PARTNERS,
a California Partnership
By: Mayfield VI Investment Partners,
a California Limited Partnership,
Its General Partner
By: Mayfield VI Management Partners,
a California limited partnership,
Its General Partner
By: /s/ George A. Pavlov
---------------------------------
Authorized Signatory
3
<PAGE> 22
Date: February 10, 1997 MAYFIELD MEDICAL PARTNERS 1992,
a California Partnership
By: Mayfield VII,
a California Limited Partnership,
Its General Partner
By: Mayfield VI Management Partners,
a California limited partnership,
Its General Partner
By: /s/ George A. Pavlov
-----------------------------
Authorized Signatory
Date: February 10, 1997 MAYFIELD ASSOCIATES FUND,
a California Limited Partnership
By: /s/ George A. Pavlov
-----------------------------
Authorized Signatory
Date: February 10, 1997 MAYFIELD ASSOCIATES FUND II,
a California Limited Partnership
By: /s/ George A. Pavlov
-----------------------------
Authorized Signatory
Date: February 10, 1997 /s/ Yogen K. Dalal
---------------------------------
YOGEN K. DALAL
Date: February 10, 1997 /s/ Kevin A. Fong
---------------------------------
KEVIN A. FONG
4
<PAGE> 23
Date: February 10, 1997 /s/ A. Grant Heidrich III
---------------------------------
A. GRANT HEIDRICH III
Date: February 10, 1997 /s/ Russell C. Hirsch
---------------------------------
RUSSELL C. HIRSCH
Date: February 10, 1997 /s/ Wende S. Hutton
---------------------------------
WENDE S. HUTTON
Date: February 10, 1997 /s/ Michael J. Levinthal
---------------------------------
MICHAEL J. LEVINTHAL
Date: February 10, 1997 /s/ F. Gibson Myers, Jr.
---------------------------------
F. GIBSON MYERS, JR.
Date: February 10, 1997 /s/ William D. Unger
---------------------------------
WILLIAM D. UNGER
Date: February 10, 1997 /s/ Wendell G. Van Auken III
---------------------------------
WENDELL G. VAN AUKEN III
5
<PAGE> 24
EXHIBIT A
<TABLE>
<CAPTION>
COLUMN I COLUMN II PERSONS/ENTITIES ON WHOSE BEHALF
- -------- --------- --------------------------------
PUBLICLY TRADED COMPANY DESIGNATED FILER THE DESIGNATED FILER MAY ACT
- ----------------------- ---------------- --------------------------------
<S> <C> <C>
ADVENT SOFTWARE, INC. MAYFIELD VII MAYFIELD VII MANAGEMENT PARTNERS,
MAYFIELD ASSOCIATES FUND II,
YKD, FGM, KAF, WDU, WVA,
MJL, AGH
BROADVISION, INC. MAYFIELD VII MAYFIELD VII MANAGEMENT PARTNERS,
MAYFIELD ASSOCIATES FUND II,
YKD, KAF, MJL
DIGITAL GENERATION SYSTEMS, MAYFIELD VII MAYFIELD VII MANAGEMENT PARTNERS,
INC. MAYFIELD ASSOCIATES FUND II,
YKD, KAF, WDU, WVA, MJL,
AGH
DIGITAL SYSTEMS MAYFIELD VI MAYFIELD VI MANAGEMENT PARTNERS,
INTERNATIONAL, INC. INVESTMENT MAYFIELD VII,
PARTNERS MAYFIELD ASSOCIATES FUND,
MAYFIELD ASSOCIATES FUND II
GYNECARE, INC. MAYFIELD VII MAYFIELD VII MANAGEMENT PARTNERS,
MAYFIELD ASSOCIATES FUND II,
YKD, FGM, KAF, WDU, MJL,
AGH, WSH
HEARTSTREAM, INC. MAYFIELD VII MAYFIELD VII MANAGEMENT PARTNERS,
MAYFIELD ASSOCIATES FUND II,
YKD, FGM, KAF, WDU, WVA,
MJL, AGH, WSH
INCONTROL, INC. MAYFIELD VI MAYFIELD VI MANAGEMENT PARTNERS,
INVESTMENT MAYFIELD MEDICAL PARTNERS,
PARTNERS YKD, FGM, KAF, WDU, WVA,
MJL, AGH
MILLENNIUM MAYFIELD VII MAYFIELD VII MANAGEMENT PARTNERS,
PHARMACEUTICALS, INC. MAYFIELD ASSOCIATES FUND II,
MAYFIELD MEDICAL PARTNERS 1992,
YKD, FGM, KAF, WDU, WVA,
MJL, AGH
</TABLE>
6
<PAGE> 25
<TABLE>
<S> <C> <C>
PRISM SOLUTIONS, INC. MAYFIELD VI MAYFIELD VI MANAGEMENT PARTNERS,
INVESTMENT MAYFIELD ASSOCIATES FUND,
PARTNERS MAYFIELD SOFTWARE TECHNOLOGY
PARTNERS,
YKD, FGM, KAF, WDU, WVA,
MJL
SPECTRALINK CORPORATION MAYFIELD VI MAYFIELD VI MANAGEMENT PARTNERS,
INVESTMENT MAYFIELD ASSOCIATES FUND,
PARTNERS YKD
</TABLE>
<TABLE>
<S> <C> <C>
YKD = Yogen K. Dalal FGM = F. Gibson Myers, Jr. KAF = Kevin A. Fong
WDU = William D. Unger WVA = Wendell G. Van Auken III MJL = Michael J. Levinthal
AGH = A. Grant Heidrich III WSH = Wende S. Hutton
</TABLE>
7
<PAGE> 26
EXHIBIT C
LIST OF GENERAL PARTNERS
The following list sets forth the General Partners with respect to certain of
the Mayfield Entities:
The General Partner of Mayfield VI Investment Partners is Mayfield VI Management
Partners. The General Partners of Mayfield VI Management Partners are:
(1) F. Gibson Myers, Jr. (4) William D. Unger
(2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III
(3) Michael J. Levinthal (6) Kevin A. Fong
The General Partner of Mayfield VII is Mayfield VII Management Partners. The
General Partners of Mayfield VII Management Partners are:
(1) F. Gibson Myers, Jr. (4) William D. Unger
(2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III
(3) Michael J. Levinthal (6) Kevin A. Fong
The General Partners of Mayfield Associates Fund are:
(1) F. Gibson Myers, Jr. (4) William D. Unger
(2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III
(3) Michael J. Levinthal
The General Partners of Mayfield Associates Fund II are:
(1) F. Gibson Myers, Jr. (4) William D. Unger
(2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III
(3) Michael J. Levinthal (6) Kevin A. Fong
(7) Yogen K. Dalal
The General Partner of Mayfield Medical Partners is: (1) Mayfield VI Investment
Partners (The General Partner of which has been detailed above)
The General Partner of Mayfield Medical Partners 1992 is:
(1) Mayfield VII (The General Partner of which has been detailed above)
The General Partners of Mayfield Software Technology Partners are:
(1) Mayfield VI Investment Partners (the General Partner of which has been
detailed above)
(2) Yogen K. Dalal